Effekten af levosimendan på systolisk deformation og diastolisk funktion hos patienter med operationskrævende aortastenose og svær hypertrofi af venstre ventrikel

Trial Profile

Effekten af levosimendan på systolisk deformation og diastolisk funktion hos patienter med operationskrævende aortastenose og svær hypertrofi af venstre ventrikel

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 01 May 2013

At a glance

  • Drugs Levosimendan (Primary)
  • Indications Aortic valve stenosis; Diastolic heart failure; Left ventricular hypertrophy
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 May 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top